Advent intends to make recommended all-cash full public offer for Mediq 

• Advent and Mediq have reached conditional agreement on a recommended full public offer by Advent for Mediq of € 13.25 (cum dividend) in cash per ordinary share, representing a premium of 53% over the closing price of Mediq on 21 September 2012
• The Management Board and Supervisory Board of Mediq fully support and unanimously recommend the Offer
• Templeton Investment Counsel and Silchester International Investors have irrevocably confirmed to support and accept the Offer, representing 20.2% of Mediqs outstanding shares
• Committed financing already in place